PRESS RELEASE published on 01/24/2025 at 08:00, 1 year 4 months ago Inside Information / Other news releases Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025 AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
BRIEF published on 11/26/2024 at 17:50, 1 year 6 months ago Median Technologies Showcases AI Lung Cancer Diagnostic at RSNA 2024 Clinical Trials Eyonis™ LCS RSNA 2024 AI-powered Diagnostics Lung Cancer Screening
PRESS RELEASE published on 11/26/2024 at 17:45, 1 year 6 months ago Inside Information / Other news releases Median Technologies to showcase AI-powered lung cancer diagnostic eyonis™ LCS at RSNA 2024. Company presents latest developments and REALITY study results to experts in medical imaging conference AI-powered Median Technologies Eyonis LCS RSNA 2024 Lung Cancer Diagnostic
BRIEF published on 10/30/2024 at 17:50, 1 year 7 months ago Median Technologies and AI in lung cancer screening Artificial Intelligence Medical Technologies Lung Cancer Webconférence 2024 Medical Screening
BRIEF published on 10/07/2024 at 17:50, 1 year 7 months ago Status of voting rights and capital of Median Technologies as of September 30, 2024 Voting Rights Capital Actions Median Technologies September 30, 2024
BRIEF published on 09/06/2024 at 17:50, 1 year 8 months ago Modification of the rights attached to the categories of shares of Median Technologies Voting Rights Capital Actions Median Technologies Modification Of Rights
PRESS RELEASE published on 09/06/2024 at 17:45, 1 year 8 months ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and shares as of August 31, 2024, in accordance with regulatory requirements. Company uses AI for cancer diagnoses and treatments globally Voting Rights Shares AI Median Technologies Cancer Diagnosis
BRIEF published on 09/04/2024 at 17:50, 1 year 8 months ago Median Technologies: Promising results for the diagnosis of lung cancer Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS Pivotal Study
PRESS RELEASE published on 09/04/2024 at 17:45, 1 year 8 months ago Inside Information / Other news releases Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software at IASLC 2024 World Conference on Lung Cancer. eyonis™ LCS achieves high accuracy in detecting lung cancer Median Technologies Lung Cancer Eyonis LCS IASLC 2024 Diagnostic Software
BRIEF published on 08/29/2024 at 17:50, 1 year 9 months ago Median Technologies: eyonis achieves REALITY study objectives Screening Median Technologies Lung Cancer Eyonis™ LCS AUC
Published on 06/02/2026 at 09:01, 1 hour 56 minutes ago Star Copper Begins Drilling at Star East Target as 15,000 Metre 2026 Exploration Campaign Gets Underway
Published on 06/02/2026 at 04:00, 6 hours 57 minutes ago Lobe Sciences Announces Proposed Shares for Debt Transaction
Published on 06/02/2026 at 03:00, 7 hours 57 minutes ago Clean Air Metals Files Audited Annual Financial Statements for the Year Ended January 31, 2026
Published on 06/01/2026 at 23:57, 11 hours ago Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million
Published on 06/02/2026 at 10:48, 8 minutes ago VIB Vermögen AG: Joint Venture with a fund managed by Tristan Capital Partners for the development of logistics real estate
Published on 06/02/2026 at 10:05, 51 minutes ago Galorath's 2026 State of the Industry Report Finds 79% of Organizations Increased AI Spending on Estimation While Only 1 in 4 Have Clear AI Policies
Published on 06/02/2026 at 10:05, 51 minutes ago JK Tech Launches Dedicated Gemini Enterprise Unit to Accelerate AI Adoption Across Enterprises
Published on 06/02/2026 at 10:00, 57 minutes ago Nik Storonsky named European Banker of the Year 2025
Published on 06/02/2026 at 10:00, 57 minutes ago PFISTERER receives patent for innovative connector technology for HVDC applications
Published on 06/02/2026 at 08:00, 2 hours 57 minutes ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 3 hours 27 minutes ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
Published on 06/02/2026 at 07:00, 3 hours 57 minutes ago BIOPHYTIS STRATEGIC UPDATE: JOINT VENTURE REGISTRATION FILING SUBMITTED IN HONG KONG
Published on 06/01/2026 at 18:47, 16 hours 10 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 16 hours 57 minutes ago Covivio - Information on total number of voting rights and share capital
